Roberts Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-34,152
Closed -$2.98M 100
2025
Q2
$2.98M Sell
34,152
-358
-1% -$30.4K 0.86% 41
2025
Q1
$3.1M Sell
34,510
-171
-0.5% -$15.3K 0.96% 35
2024
Q4
$2.96M Sell
34,681
-15,334
-31% -$1.33M 0.9% 37
2024
Q3
$4.41M Buy
50,015
+850
+2% +$71.5K 1.43% 24
2024
Q2
$3.78M Buy
49,165
+1,596
+3% +$131K 1.29% 26
2024
Q1
$3.82M Buy
47,569
+1,137
+2% +$97K 1.43% 25
2023
Q4
$12.1M Buy
46,432
+1,987
+4% +$151K 1.89% 19
2023
Q3
$3.19M Buy
44,445
+778
+2% +$65.1K 1.4% 25
2023
Q2
$3.85M Sell
43,667
-84
-0.2% -$7.23K 1.69% 20
2023
Q1
$3.48M Buy
43,751
+11,370
+35% +$927K 1.59% 20
2022
Q4
$2.53M Sell
32,381
-5,852
-15% -$474K 1.22% 30
2022
Q3
$3.23M Buy
38,233
+169
+0.4% +$15.2K 1.59% 18
2022
Q2
$3.41M Buy
38,064
+1,199
+3% +$121K 1.48% 21
2022
Q1
$4.15M Buy
36,865
+1,180
+3% +$125K 1.63% 17
2021
Q4
$3.79M Buy
35,685
+809
+2% +$93.7K 1.36% 23
2021
Q3
$4.37M Buy
+34,876
New +$4.51M 1.73% 14

Other funds holding MDT

Roberts Wealth Advisors's MDT Position: Q3 2025 in Review

Roberts Wealth Advisors sold out of Medtronic (MDT) in Q3 2025, closing a stake of 34,152 shares — an estimated $2.98M sold.

Roberts Wealth Advisors first reported a position in MDT in Q3 2021 and held it in 16 quarters. The position peaked at $12.1M in Q4 2023. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Roberts Wealth Advisors reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Roberts Wealth Advisors sold 34,152 Medtronic shares in Q3 2025, an estimated $2.98M.
  • Roberts Wealth Advisors first reported a position in Medtronic in Q3 2021 and held it in 16 quarters.
  • Roberts Wealth Advisors's Medtronic position peaked at $12.1M in Q4 2023.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Roberts Wealth Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.